Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$3.56
+3.04%today
MKT CAP
$133M
+9.9% · 1Y
Earnings History
-27.8%
-6.2%
+42.8%
-62.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$3.56
Low
$2.50
Analyst Mean
$5.50
High
$10.00
3 analystsNone
Full Financials
Trailing P/E-
Forward P/E-7.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+37.0%
5y Revenue CAGR+6.4%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership9.8%
Institutional Ownership39.0%
Short % of Float0.24%
Days to Cover1.2d
1 Week+8.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | institution | 19.50% | $0.03B | +0.00% | 2025-12-31 |
| Morgan Stanley | institution | 8.94% | $0.01B | -0.29% | 2025-12-31 |
| Rock Springs Capital Management, LP | institution | 3.43% | $0.00B | +1.30% | 2025-12-31 |
| Flax Pond Capital, LLC | institution | 2.13% | $0.00B | +100.00% | 2025-12-31 |
| Bruce & Co, Inc. | institution | 1.17% | $0.00B | +0.00% | 2025-12-31 |
| Bruce Fund, Inc.-BRUCE FUND | fund | 1.11% | $0.00B | +0.00% | 2025-12-31 |
| UBS Group AG | institution | 0.56% | $0.00B | -11.20% | 2025-12-31 |
| Parkman Healthcare Partners LLC | institution | 0.41% | $0.00B | +0.00% | 2025-12-31 |
| Schonfeld Strategic Advisors Llc | institution | 0.37% | $0.00B | -18.51% | 2025-12-31 |
| Cahill Financial Advisors Inc. | institution | 0.36% | $0.00B | +0.00% | 2025-12-31 |
| US BANCORP \DE\ | institution | 0.32% | $0.00B | +100.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.06% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for EDAP.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.